CALYX REMEDIES PRIVATE LIMITED
CALYX REMEDIES PRIVATE LIMITED is a GUJARAT based PRIVATE LIMITED company, Registered at dated 16-JUN-1997 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of CALYX REMEDIES PRIVATE LIMITED is U24230GJ1997PTC032517 and registration number is 032517.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies AHMEDABAD India. Authorized share capital of CALYX REMEDIES PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 100000. It aspire to serve in METALS, CHEMICALS AND PRODUCTS THEREOF MANUFACTURING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
CALYX REMEDIES PRIVATE LIMITED has 2 directors SHRIKANT SINGH CHINGTHAM, JANAK BAROT,
The registered Email address of CALYX REMEDIES PRIVATE LIMITED is dr_chandresh1@yahoo.co.in and its registered address is 101 ASHRAM AVENUEB/H KOCHRAB ASHRAM ASHRAM ROAD AHMEDABAD AHMEDABAD GJ 380006 IN GUJARAT GUJARAT india 380006.
The current status of CALYX REMEDIES PRIVATE LIMITED shows as STRIKE OFF
COMPANY BASIC DETAILS
CALYX REMEDIES PRIVATE LIMITED
AHMEDABAD
STRIKE OFF
METALS, CHEMICALS AND PRODUCTS THEREOF MANUFACTURING
U24230GJ1997PTC032517
16-JUN-1997
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
100000
CONTACT DETAILS
380006
INDIA
101 ASHRAM AVENUEB/H KOCHRAB ASHRAM ASHRAM ROAD AHMEDABAD AHMEDABAD GJ 380006 IN
dr_chandresh1@yahoo.co.in
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
02046317 | SHRIKANT SINGH CHINGTHAM | Director | 01/03/2008 |
02056380 | JANAK BAROT | Director | 01/03/2008 |
Details Updated by Companies
Quick Links
- All Registered company of GUJARAT
- Company Registered in GUJARAT
- All Registered company of AHMEDABAD in GUJARAT
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.